StockData
PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc. (PTCT) bonds

PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.36−0.61 (-1.00%)

Close on Nov 17, 2026Market cap $5.04BP/E –Yield –

Debt

Borrowings on the balance sheet, Sep 30, 2026

Total debt
$536.27M
Long-term debt
Net debt
$27.37M
After $508.89M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in PTC Therapeutics's 10-Q for the period ended Sep 30, 2026

IssueCouponMaturesAmount issuedCarrying value
2031 Convertible Notes
Convertible
0.00%2031$550.00M–
2031 Convertible Notes
Convertible at $107 a share
0.00%2031$550.00M$550.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?